| Literature DB >> 34368491 |
Marta F D Trindade1, Rui A Viana1,2.
Abstract
BACKGROUND: External stimuli can improve gait performance in Parkinsons Disease (PD): auditory stimuli can increase velocity and visual stimuli may act at step length.Entities:
Keywords: Parkinson disease; auditory perception; exercise; gait; physical therapy modalities; visual perception
Year: 2021 PMID: 34368491 PMCID: PMC8341369 DOI: 10.1097/j.pbj.0000000000000140
Source DB: PubMed Journal: Porto Biomed J ISSN: 2444-8664
Characteristics of study participants
| Participants | |||||||
|---|---|---|---|---|---|---|---|
| References | Study design/CASP score | Sample size | Age (mean ± standard deviation) | Sex (M/W) | Disease duration (mean ± Standard deviation) | Dropouts (timeframe) | Stage of PD∗ |
| Agosta et al, 2017 [ | Cohort study(10/14) | IG1 = 12IG2 = 13CG = 19 | (64.0 ± 7.0)(69.0 ± 8.0)(66.0 ± 8.0) | 10/28/59/10 | – | – | II–III |
| Bukowska et al, 2015[ | Cohort study(9/14) | IG = 30CG = 25 | (63.4 ± 10.6)(63.4 ± 9.7) | 15/1515/10 | (5.5 ± 3.9)(6.8 ± 4.3) | – | II–III |
| Pau et al, 2016[ | Cohort study(12/14) | IG = 26CG = - | (70.4 ± 9.0)– | 20/6– | (7.5 ± 5.4)- | 5 (−)- | I–III |
| Schlick et al, 2016[ | Randomized controlled trial(6/10) | IG = 10CG = 10 | (71.2 ± 10.9)(68.9 ± 6.8) | 2/84/6 | (10.4 ± 5.2)(9.1 ± 3.1) | 2 (6 wk after study start)4 (2 mo follow-up)1 (6 wk after study start)3 (2 mo follow-up) | II–IV |
| Stuart et al, 2018[ | Case control study(8/12) | IG = 55CG = 32 | (67.9 ± 7.9)(67.0 ± 10.8) | 36/1915/17 | 60.0 (-)– | – | I–III |
- = unspecified information; CG = control group; IG = intervention group; M = man; PD = Parkinsons disease; RCT = randomized controlled trial; W = woman.
Parkinson disease stage according to Hoehn and Yahr Scale.
Characteristics of intervention group and control group
| References | External sensory stimuli (yes/no) | IG protocol (duration, frequency) | CG protocol |
|---|---|---|---|
| Agosta et al, 2017[ | Auditory: yesVisual: no | 8 wk; 3 times per week60 min of training (24 min of observation and 36 min of precision imitation to the rhythm of the auditory stimuli), during ON time, under the supervision of a physiotherapist.IG1 = Observation and subsequent practice of actions at the rate of auditory stimuli.IG2 = Same exercise training through physiotherapists instructions, only combined with the observation of landscape videos. | At baseline, the healthy controls performed neuropsychological and magnetic resonance imaging assessments. |
| Bukowska et al, 2015[ | Auditory: yesVisual: no | 4 wk; 4 times per week.45 min per session of neurological music therapy, with warm-up exercises, daily life activities, pregait, and with gait pattern stimulation through rhythmic auditory stimulation, and in the end, the breathing exercises. | Maintenance of daily life activities. |
| Pau et al, 2016[ | Auditory: yesVisual: no | 5 wk, 2 times per week.45 min of exercises to improve mobility, balance, posture, and gait. Twenty minutes of each session consisted of a paced gait with soundtracks through a portable MP3 player and headphones.In addition, the training was performed at home, including 30 min of walking with rhythmic auditory clues. | - |
| Schlick et al, 2016[ | Auditory: noVisual: yes | 5 wk, 2 to 3 times per week.Treadmill training combined with visual stimuli. | Unique treadmill training. |
| Stuart et al, 2018[ | Auditory: noVisual: yes | -7 m in self-selected pace and different walking conditions, with 3 attempts in each condition.1) Single task (straight walking);2) Single task with visual stimuli (tape with black lines, placed 50 cm apart and transverse to the starting point);3) Double task (maximum forward digit range and gait);4) Double task with visual stimuli. | Same protocol as the IG. |
- = unspecified information; CG = control group; IG = intervention group; MP3 = moving picture experts group layer.
Results of randomized controlled trials
| IG | CG | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| References | Variable | Baseline | End of treatment | Follow-up | Baseline | End of treatment | Follow-up | ||
| Schlick et al, 2016[ | a | 1.7 ± 0.8 | 2.6 ± 0.7 | 2.6 ± 0.5 | .000 | 2.4 ± 0.7 | 3.5 ± 0.9 | 2.5 ± 1.1 | .001 |
| b | 61.1 ± 29.6 | 90.4 ± 21.7 | 78.4 ± 23.4 | .001 | 75.1 ± 18.2 | 104.5 ± 21.7 | 82.2 ± 25.2 | .002 | |
| c | 9.9 ± 28.1 | 95.4 ± 10.9 | 95.6 ± 8.4 | .665 | 107.4 ± 21.8 | 110.0 ± 13.2 | 99.7 ± 23.1 | .650 | |
| d | 14.4 ± 6.8 | 11.8 ± 5.5 | 10.9 ± 4.4 | .006 | 10.9 ± 4.7 | 10.8 ± 4.0 | 10.4 ± 5.0 | .237∗ | |
| e | 28.9 ± 13.8 | 23.8 ± 13.5 | 21.8 ± 13.4 | .019 | 25.3 ± 15.1 | 23.4 ± 10.1 | 28.2 ± 13.7 | – | |
| f | 9.6 ± 5.7 | 10.0 ± 6.9 | 3.2 ± 4.1 | .001∗ | 10.5 ± 6.2 | 9.8 ± 6.5 | 4.2 ± 4.5 | .521∗ | |
The P values are relative to the results obtained after the 2-month follow-up.
- = unspecified information; CG = Control group; IG = Intervention group; P = significance level; a = walking speed; b = stride length; c = cadence; d = Time Up and Go Test; e = Unified Parkinsons Disease Rating Scale—Part III; f = Freezing of Gait Questionnaire.
Results of case-control studies
| IG | CG | |||||
|---|---|---|---|---|---|---|
| References | Task | Variable | β | β | ||
| Stuart et al, 2018[ | Δ CUE | a | −0.281 | .097 | 0.232 | .410 |
| b | −0.294 | .101 | – | – | ||
| c | −0.346 | .057 | −0.055 | .813 | ||
| d | 0.154 | .326 | −0.139 | .500 | ||
| e | −0.348 | .035 | 0.050 | .859 | ||
| f | 0.209 | .189 | 0.061 | .814 | ||
| g | −0.129 | .411 | −0.067 | .812 | ||
| h | 0.190 | .167 | 0.125 | .621 | ||
| I | −0.008 | .961 | 0.026 | .917 | ||
| Δ CUE - DUAL | j | −0.451 | .033 | 0.199 | .407 | |
| a | 0.121 | .513 | 0.300 | .270 | ||
| b | −0.290 | .143 | – | – | ||
| c | −0.010 | .960 | −0.136 | .544 | ||
| d | 0.080 | .644 | 0.183 | .358 | ||
| e | −0.077 | .666 | −0.472 | .090 | ||
| f | 0.116 | .509 | 0.455 | .078 | ||
| g | −0.043 | .804 | −0.241 | .380 | ||
| h | −0.133 | .379 | −0.104 | .667 | ||
| I | 0.120 | .531 | −0.221 | .359 | ||
| j | 0.066 | .772 | 0.051 | .822 | ||
- = unspecified information; β = regression coefficient; CG = control group; IG = intervention group; P = significance level; a = age; b = Unified Parkinsons Disease Rating Scale—part III; c = Montreal Cognitive Assessment; d, = Geriatric Depression Scale; e = fluctuation of attention; f = judgment of line orientation; g = Executive Clock Drawing Test; h = digit span; i = visual acuity; j = contrast sensitivity.
Results of cohort studies
| IG | CG | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| References | Variable | Baseline | End of treatment | Follow-up | Baseline | End of treatment | Follow-up | ||
| Bukowska et al, 2015[ | a | – | 62.2 ± 1.5 | – | <.001 | – | 63.2 ± 2.0 | – | .131 |
| b | – | 37.8 ± 1.5 | – | <.001 | – | 36.9 ± 2.0 | – | .056 | |
| c | – | 12.3 ± 1.5 | – | <.001 | – | 13.2 ± 2.1 | – | .065 | |
| d | – | 1.0 ± 0.1 | – | <.001 | – | 1.1 ± 0.1 | – | .438 | |
| e | – | 116.6 ± 9.1 | – | .001 | – | 113.1 ± 12.8 | – | .545 | |
| f | – | 0.5 ± 0.1 | – | <.001 | – | 0.5 ± 0.1 | – | .035 | |
| g | – | 1.2 ± 0.2 | – | <.001 | – | 1.1 ± 0.2 | – | .03 | |
| h | – | 1.2 ± 0.2 | – | <.001 | – | 1.1 ± 0.2 | – | .038 | |
| i | – | 0.2 ± 0.0 | – | .172 | – | 0.2 ± 0.0 | – | .107 | |
| Pau et al, 2016[ | f | 0.5 ± 0.1 | 0.6 ± 0.1 | 0.6 ± 0.1 | <.001 | – | – | – | – |
| g | 1.1 ± 0.3 | 1.2 ± 0.3 | 1.2 ± 0.3 | <.001 | – | – | – | – | |
| e | 114.6 ± 13.4 | 120.8 ± 9.4 | 120.6 ± 12.3 | .024 | – | – | – | – | |
| i | 0.2 ± 0.0 | 0.2 ± 0.0 | 0.2 ± 0.1 | <.001 | – | – | – | – | |
| a | 61.1 ± 2.8 | 59.4 ± 3.1 | 60.1 ± 2.0 | .002 | – | – | – | – | |
| b | 38.7 ± 2.6 | 40.3 ± 2.5 | 39.9 ± 2.0 | .004 | – | – | – | – | |
| c | 11.6 ± 2.6 | 10.2 ± 2.1 | 10.2 ± 2.0 | .002 | – | – | – | – | |
- = unspecified information; CG = control group; IG = intervention group; P = significance level; a = support phase; b = balance phase, c = double support phase, d = stride time; e = cadence; f = step length, g = speed; h = stride length; i = stride width; j = Hoehn e Yahr Scale mode ON; k = Unified Parkinsons Disease Rating Scale—Part III mode ON; l = Freezing of Gait Questionnaire; m = Unified Parkinsons Disease Rating Scale—Part II (Freezing of Gait Questionnaire) mode ON; n, Parkinsons Disease Questionnaire; o = Berg Balance Scale; p = walking test at a distance of 10 m at comfortable speed; q = walking test at a distance of 10 m at maximum speed.
∗The article of Agosta et al (2017) presents 2 IGs, requiring a different table from the other cohort studies.
Figure 1Flowchart of article selection according to items for systematic reviews and meta-analyses (PRISMA) (Moher, Liberati, Tetzlaff e Altman, 2009).